Susanne Gahr

EGFR mutational status in a large series of Caucasian European NSCLC patients: data from daily practice

Susanne Gahr, Robert Stoehr, Eva Geissinger et al. · British Journal of Cancer · 2013 · 152 citations · Full text

Medicine, Genetics, Oncology +13

The pan-deacetylase inhibitor panobinostat inhibits growth of hepatocellular carcinoma models by alternative pathways of apoptosis.

Pietro Di Fazio, Regine Schneider‐Stock, Daniel Neureiter et al. · PubMed · 2010 · 61 citations · Full text

Medicine, Oncology, Pharmacology +17

The Expression Pattern of PDX-1, SHH, Patched and Gli-1 Is Associated with Pathological and Clinical Features in Human Pancreatic Cancer

Karl Quint, Sebastian Stintzing, Beate Alinger et al. · Pancreatology · 2008 · 48 citations · Full text

Medicine, Oncology, Pathology +10

Inhibition of DNA methyltransferase activity and expression by treatment with the pan-deacetylase inhibitor panobinostat in hepatocellular carcinoma cell lines

Steffen Zopf, Matthias Ocker, Daniel Neureiter et al. · BMC Cancer · 2012 · 46 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

The combination of the histone-deacetylase inhibitor trichostatin A and gemcitabine induces inhibition of proliferation and increased apoptosis in pancreatic carcinoma cells

Susanne Gahr, Matthias Ocker, Marion Ganslmayer et al. · International Journal of Oncology · 2007 · 31 citations · Full text

Medicine, Oncology, Pharmacology +15